Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-06-15
1997-05-27
Reamer, James H.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
5483147, 546203, C07D41100
Patent
active
056333820
ABSTRACT:
The present invention provides novel compounds having activity as histamine H.sub.3 -receptor antagonists. The novel compounds include 4-imidazolyl-N-substituted pyrrolidines, piperidines, and cycloheptimides. The preferred compounds are 4-imidazolyl-N-(cycloalkyl/aryl-alkyl-carbonyl) piperidines such as 4-(1-cyclohexylvaleryol-4-piperidyl)-1H-imidazole.
REFERENCES:
patent: 4707487 (1987-11-01), Arrang et al.
patent: 4767778 (1988-08-01), Arrang et al.
patent: 5034539 (1991-07-01), Arrang et al.
patent: 5070101 (1991-12-01), Kaminski
patent: 5290790 (1994-03-01), Arrang et al.
Arrang et al., 1983, "Auto-inhibition of brain histamine release mediated by a novel class (H.sub.3) of histamine receptor," Nature 302:832-837.
Janssens et al., 1985, "New antihistaminic N-heterocyclic 4-piperidinamines. 3. Synthesis and antihistaminic activity of N-(4-piperidinyl)-3H-imidazo [4,5-b] pyridin-2-amines," J. Med. Chem. 28:1943-1947.
Arrang et al., 1985, "Steroselectivity of the histamine H.sub.3 -presynaptic autoreceptor," Eur. J. Pharmacol. 117:109-114.
Arrang et al., 1987, "Highly potent and selective ligands for histamine H.sub.3 -receptors," Nature 327:117-123.
Arrang et al., 1988, "H.sub.3 -receptors control histamine release in human brain," J. Neurochem. 51:105-108.
Arrang et al., 1988, "Int er et potential de ligands puissants et specifiques du recepteur H.sub.3 de I'histamine," Allergie Immunol. 20:327-331.
Arrang et al., 1988, "Highly potent and selective ligands for a new class H.sub.3 of histamine receptor," Invest. Radiol. 23 (Suppl. 1):S130-S132.
Timmerman, 1990, "Histamine H.sub.3 ligands: just pharmacological tools or potential therapeutic agents," J. Med. Chem. 33:4-11.
Cooper et al., 1990, "Histamine receptors," In Comprehensive Medicinal Chemistry, vol. 3, Pergamon Press, Chapter 12.5, pp. 323-421.
Schwartz et al., 1990, "A third histamine receptor subtype: characterization, localization and functions of the H.sub.3 -receptor," Agents and Actions 30:13-23.
West et al., 1990, "Identification of two H.sub.3 -histamine receptor subtypes," Mol. Pharmacol. 38:610-613.
Lipp et al., 1991, "Novel chiral H.sub.3 -receptor agonists," in New Perspectives in Histamine Research, Birkh auser Verlag: Basel, pp. 277-282.
Poli et al., 1991, "Histamine H.sub.3 -receptor activation inhibits acetylcholine release from the guinea pig myenteric plexus," Agents and Actions 33:167-169.
Bent et al., 1991, "The influence of H.sub.1, -H.sub.2 -and H.sub.3 -receptors on the spontaneous and Con A induced histamine release from human adenoid mast cells," Agents and Actions 33:67-70.
Ganellin et al., 1991, "Synthesis of pyridyl isosteres of this peramide as H.sub.3 -receptor histamine antagonists," Collect. Czech. Res. Commun. 56:2448-2455.
Arrang et al., 1991, "The histamine H.sub.3 -receptor: pharmacology, roles and clinical implications studied with agonists, in New Perspectives In Histamine Research", Birkh auser Verlag: Basel, pp. 55-67.
Leurs et al., 1992, "The histamine H.sub.3 -receptor: a target for developing new drugs", Prog. Drug Res. 39:127-165.
Yoshimatsu et al., 1993, "Abnormalities in obese zuckers: defective control of histaminergic functions," Physiology & Behavior 54:487-491.
Khan et al., 1993, "Synthesis and H.sub.3 -receptor affinities of isomeric N-methyl-and N-benzyl-imidazole derivatives of thioperamide," Med. Chem. Res. 3:428-437.
Durant Graham J.
Khan Amin M.
Reamer James H.
The University of Toledo
LandOfFree
Histamine H.sub.3 -receptor antagonists and therapeutic uses the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Histamine H.sub.3 -receptor antagonists and therapeutic uses the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Histamine H.sub.3 -receptor antagonists and therapeutic uses the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2330211